Portcullis Surgery

Portcullis Surgery

Portcullis Lane, Ludlow, SY8 1GT

Current time is 05:24 - Sorry, we're closed

NHS

Telephone: 01584 872 939

Fax: 01584 879 031

portcullis.surgery@nhs.net

IMPORTANT MESSAGE FOR PATIENTS WHO ARE OVER 50 OR WHO HAVE UNDERLYING CONDITIONS WHO HAVE TESTED POSITIVE FOR COVID 19 IN THE LAST 5 DAYS

Posted on January 3rd, 2022

IMPORTANT MESSAGE FOR PATIENTS WHO ARE OVER 50 OR WHO HAVE UNDERLYING CONDITIONS WHO HAVE TESTED POSITIVE FOR COVID 19 IN THE LAST 5 DAYS
 
WHAT IS THE PANORAMIC STUDY AND WHY SHOULD I SIGN UP?
 
The NHS is offering new antibody and antiviral treatments to people with coronavirus (COVID-19) who are at highest risk of becoming seriously ill.
2 types of COVID-19 treatment are available:
sotrovimab (Xevudy)-AVAILABLE ONLY TO SHIELDED PATIENTS
molnupiravir (Lagevrio)-AVAILABLE TO ALL HIGHER RISK PATIENTS AND PATIENTS OVER THE AGE OF 50
 
These treatments can help some people manage their COVID-19 symptoms and reduce the risk of becoming seriously ill.
 
MOLNUPIRAVIR (PANORAMIC STUDY)
 
Molnupiravir is an antiviral ORAL medicine. Patients eligible to participate IN THE PANORAMIC STUDY include those with:
 
Covid-19 symptoms which have begun in the last five days and
Positive PCR test for Covid 19
and
Aged 50 and over or aged 18-49 with a pre-existing condition.
 
Pre-existing conditions are as follows:
Respiratory disease (COPD, cystic fibrosis, asthma requiring at least daily medication)
Chronic heart or vascular disease
Chronic kidney disease
Chronic liver disease
Chronic neurological disease (eg, dementia, stroke, epilepsy)
Down’s syndrome
Type 1 or 2 diabetes
Immunosuppression due to disease or treatment
Recipient of a transplant (solid organ, bone marrow or stem cell)
Obesity with a BMI >35
Severe mental illness
Resident of a care home
Judged by the recruiting clinician or research nurse to be clinically vulnerable
 
HOW CAN HIGHER RISK PATIENTS ACCESS TREATMENT WITH MOLNUPIRAVIR (PANORAMIC STUDY)
 
Patients who are in the at risk list above AND TEST POSTIVE and wish to be considered for the study can apply to join this study by contacting their website on
https://www.panoramictrial.org/participant-information
Contact Information for Panoramic Study
Email: PANORAMIC@phc.ox.ac.uk
Freephone: 0808 156 0017
 
IF YOU TEST POSITIVE FOR COVID you may get a text from the practice as follows:
 
Positive Covid 19 Test- Panoramic Study
We have received information from Public Health England that you have recently tested positive for Covid-19. If you are feeling unwell or SOB please call 119 or call the practice for help and advice. You may be eligible to sign up for the PANORAMIC STUDY please visit the website for information. https://www.panoramictrial.org/participant-information
 
WHAT ABOUT TREATMENT FOR SHIELDED PATIENTS?
 
Sotrovimab is a biological medicine. It is also known as a neutralising monoclonal antibody (nMAb). It is only available to patients who are at the highest risk from Covid-19 or SHIELDED.
 
It is given intravenously IN HOSPITAL, within 5 days of symptom onset. One trial found a single dose of sotrovimab reduced the risk of hospitalisation and death by 85% when given to high risk unvaccinated hospitalised patients with Covid 19.
 
https://www.nejm.org/doi/full/10.1056/NEJMoa2107934
 
HOW CAN SHIELDED PATIENTS ACCESS TREATMENT WITH SOTROVIMAB?
 
Trusts and CCGs are in the process of writing to patients in the highest risk group (by LETTER or email) so that they know that they may be eligible for treatment in a CMDU if they test positive for Covid-19.
 
If you feel you are shielded and have not had the letter below and not received your priority PCR by the 10th of January you should call 119 in order to get a PCR.
 
https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2021/12/C1480-patient-notification-letter-important-information-about-new-treatments-for-coronavirus.pdf
 
This group of patients will be sent a PCR test to keep at home so that they can do the test rapidly if they develop symptoms.
 
If they test positive, the local CMDU should contact them directly to discuss and arrange treatment. If you have not been contacted within 24 hours of your positive test you should call the practice or 119 for a referral for intravenous antiviral treatment.
 
You may get a text from the practice as follows:
Positive Covid 19 Test-Shielded
We have received information from Public Health England that you have recently tested positive for Covid-19 and we believe you are at higher risk. If you are feeling unwell or SOB please call 119 or call the practice for help and advice. If you have not been contacted within 24 hours of your positive test you should call the practice or 119 for a referral for intravenous antiviral treatment.
 
A list of those considered to be at the highest risk (SHIELDED) is given below.
 
Down’s syndrome and other genetic conditions that might reasonably be expected to reduce immune competence
Sickle cell disease
Solid cancers, or patients who have received radiotherapy within the last six months or chemotherapy within the last 12 months.
Certain patients with a haematologic malignancy – eg, those within 12 months of a stem cell transplant, who have active graft vs host disease or who are within 3-6 months of various therapies.
Renal disease including those with a transplant (or a failed transplant within the last 12 months), all those with CKD 4 or 5 and those who have had B cell depleting therapy in the past 12 months or are otherwise immunosuppressed.
Liver disease including cirrhosis, transplant and immunosuppression due to therapy for liver disease.
Immune mediated inflammatory disorders, including immunosuppression due to medication
Primary immune deficiencies
HIV or AIDS where the viral load is high or the CD4 count is <350 cells/mm3 (or > cells/mm3 that with additional risk factors)
Recipients of solid organ transplants not covered in other categories
Neurological conditions – multiple sclerosis, motor neurone disease, myasthenia gravis and Huntington’s disease.
Where an nMAB is contraindicated, not recommended or the administration of a nMAB is not possible, patients may be treated with a five-day course of molnupiravir, provided the onset of symptoms is in the last 5 days.
 
For more information please visit our website
 
https://portcullis-surgery.co.uk/new-antibody-and-antiviral-treatments-for-people-with-covid-19-who-are-at-higher-risk-of-becoming-seriously-ill/

Opening Times

  • Monday
    08:30 until 20:00
    6-8pm Pre-booked appointments only.Call 111 for advice OOH
  • Tuesday
    08:30 until 20:00
    6-8pm Pre-booked appointments only.Call 111 for advice OOH
  • Wednesday
    08:30 until 20:00
    6-8pm Pre-booked appointments only.Call 111 for advice OOH
  • Thursday
    08:30 until 18:30
    Call 111 for advice OOH
  • Friday
    08:30 until 20:30
    Open 1-2 Fridays a month. 6-8pm Pre-booked appointments only.Call 111 for advice OOH
  • Saturday
    08:30 until 12:30
    Open 1-2 Sat per month Pre-booked appointments only. Call 111 for advice OOH
  • Sunday
    CLOSED
    Call 111 for advice OOH